home / stock / agtc / agtc news

AGTC News and Press, Applied Genetic Technologies Corporation From 05/02/22

Stock Information
Company Name: Applied Genetic Technologies Corporation
Stock Symbol: AGTC
Market: NASDAQ
Website: agtc.com
Menu
AGTC AGTC Quote AGTC Short AGTC News AGTC Articles AGTC Message Board
Get AGTC Alerts

News, Short Squeeze, Breakout and More Instantly...
AGTC - AGTC to Present Preclinical Research Supporting Gene Therapy Platform in Frontotemporal Dementia at the 25th Annual Meeting of the American Society of Gene & Cell Therapy

GAINESVILLE, Fla. and CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a clinical stage biotechnology company focused on the development of adeno-associated virus (AAV)-based gene therapies for the treatment of rare and de...
AGTC - AGTC to Present at Cell & Gene Meeting on the Mediterranean

GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 14, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a clinical stage biotechnology company focused on the development of adeno-associated virus (AAV)-based gene therapies for the treatment of rare and debilitati...

AGTC - Shares of Applied Genetic Technologies Corporation (AGTC) Have Risen Above Previous 52-Week High

Shares of Applied Genetic Technologies Corporation (NASDAQ:AGTC) traded at a new 52-week high today of $18.44. Approximately 62.5 million shares have changed hands today, as compared to an average 30-day volume of 718,000 shares. Potential upside of 20.2% exists for Applied Genetic Techn...

AGTC - AGTC to Showcase Interim Findings from Ongoing XLRP and Achromatopsia Phase 1/2 Trials at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting

GAINESVILLE, Fla., and CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a clinical stage biotechnology company focused on the development of adeno-associated virus (AAV)-based gene therapies for the treatment of rare and...
AGTC - IQ, NEW and QNRX among mid-day movers

Gainers: JX Luxventure (LLL) +214%. Draganfly (DPRO) +83%. Zhangmen Education (ZME) +64%. Antelope Enterprise Holdings Limited (AEHL) +37%. Society Pass (SOPA) +31%. Ever-Glory International Group (EVK) +33%. iQIYI (IQ) +26%. Alzamend Neuro (ALZN) +23%. FreightCar America (RAIL) +24%. Puxin (...

AGTC - TCR2 Therapeutics leads healthcare gainers; ORIC Pharmaceuticals, Graphite Bio among losers

Gainers: TCR2 Therapeutics (TCRR) +16%. Precision BioSciences (DTIL) +16%. Alzamend Neuro (ALZN) +15%. BioSig Technologies (BSGM) +13%. Applied Therapeutics (APLT) +13%. Losers: ORIC Pharmaceuticals (ORIC) -29%. Applied Genetic Technologies (AGTC) -28%. NeuroSense Therapeutics (NRSN...

AGTC - Applied Genetic Technologies plunges on $9.8M stock offering

Applied Genetic Technologies (NASDAQ:AGTC) plunged 28.3% premarket after it priced its earlier announced underwritten public offering of 7.5M shares for gross proceeds of ~$9.8M. Underwriters granted 30-day option to purchase up to ~1.125M shares. Offer is expected to clos...
AGTC - AGTC Announces Pricing of Public Offering of Common Stock

GAINESVILLE, Fla., and CAMBRIDGE, Mass., March 22, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a clinical-stage biotechnology company focused on the development and commercialization of adeno-associated virus (AAV)-based gene therapies for the treatment...

AGTC - Okta, ZIM Integrated Shipping Services, Upstart Holdings among premarket losers' pack

Applied Genetic Technologies (AGTC) -24% after proposes stock offering to fund clinical programs. ZIM Integrated Shipping Services (ZIM) -15%. Dave (DAVE) -13% on Q4 earnings release. Edesa Biotech (EDSA) -13% on pricing $10.0M stock offering. Dermata Therapeutic...

AGTC - Applied Genetic Technologies proposes stock offering to fund clinical programs; slides 18%

Applied Genetic Technologies (NASDAQ:AGTC) said it has started a public offering of its common stock that will see underwriters' overallotment option to purchase up to an additional 15% of shares offered. Size, price and other terms of the offering not yet determined. The company intends to u...
Previous 10 Next 10